Literature DB >> 23373029

Pharmacovigilance of the cutaneous drug reactions in outpatients of dermatology department at a tertiary care hospital.

Inbaraj S D1, Muniappan M, Muthiah N S, Arul Amutha, Glory Josephine I, Farhana Rahman.   

Abstract

OBJECTIVE: To study the various clinical patterns, causality, severity, and preventability of cutaneous drug reactions among the out patients of the Dermatology Department in a tertiary care hospital.
METHODS: One hundred eighty one patients with suspected drug allergy were screened and 59 patients with Cutaneous Drug Reactions (CDRs) were recruited for this observational study which was conducted among the outpatients in the Department of Dermatology from June to December 2011. The history of drug intake, the morphology of the cutaneous reactions and their causality, severity and preventability were analyzed.
RESULTS: The mean age of the patients with the cutaneous drug reactions was 30.5 years. Most of them were in the age group of 26-37 years, with 52.5% females and 47.5% males. The most common reactions observed were urticaria (32.2%), fixed drug eruptions (25.4%), acneform eruptions (13.6%), morbilliform eruptions (6.8%), maculopapular rashes (5.1%), and angio-oedema (3.4%) . The most common drugs which caused the reactions were Non Steroidal Anti-Inflammatory Drugs (NSAIDs) (39.1%), Quinolones (22.1%), Amoxicillin (8.5%) and Corticosteroids (8.5%). Most of the reactions were mild to moderate in severity and all of them were preventable.
CONCLUSION: The patterns of the cutaneous adverse drug reactions and the drugs which caused them varied in our study population according to the pattern of the drug intake, the associated illness and the susceptibility of the patients. A sound knowledge of the adverse drugs reactions, a careful history taking and a cautious approach during the prescription of new drugs can prevent most of these adverse drug reactions.

Entities:  

Keywords:  Cutaneous drug reactions; Observational study; Pharmacovigilance

Year:  2012        PMID: 23373029      PMCID: PMC3552205          DOI: 10.7860/JCDR/2012/4809.2645

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

Review 1.  Cutaneous drug reactions.

Authors:  C K Svensson; E W Cowen; A A Gaspari
Journal:  Pharmacol Rev       Date:  2001-09       Impact factor: 25.468

2.  Innate immunity, insulin resistance and type 2 diabetes.

Authors:  J M Fernández-Real; J C Pickup
Journal:  Diabetologia       Date:  2011-11-30       Impact factor: 10.122

3.  Focusing on the preventability of adverse drug reactions.

Authors:  G T Schumock; J P Thornton
Journal:  Hosp Pharm       Date:  1992-06

4.  Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India.

Authors:  David Pudukadan; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2004 Jan-Feb       Impact factor: 2.545

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.

Authors:  V K Sharma; G Sethuraman; B Kumar
Journal:  J Postgrad Med       Date:  2001 Apr-Jun       Impact factor: 1.476

7.  Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study.

Authors:  Mukeshkumar B Vora; Hiren R Trivedi; Bharatbhai K Shah; C B Tripathi
Journal:  J Pharmacol Pharmacother       Date:  2011-01
  7 in total
  4 in total

1.  Cutaneous adverse drug reactions in Indian population: A systematic review.

Authors:  Tejas K Patel; Sejal H Thakkar; Dc Sharma
Journal:  Indian Dermatol Online J       Date:  2014-12

2.  A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.

Authors:  Niharika Jha; Emy Alexander; Bimal Kanish; Dinesh K Badyal
Journal:  Indian Dermatol Online J       Date:  2018 Sep-Oct

3.  Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care Hospital.

Authors:  Shweta Sharma; Dhanya Jayakumar; Dhanya S Palappallil
Journal:  Indian Dermatol Online J       Date:  2019-08-28

4.  Cutaneous Adverse Drug Reactions in a Tertiary Teaching Hospital: A Prospective, Observational Study.

Authors:  Anuja Jadhav; Sharmila Patil; Isheeta Manchanda; Ruchita Hasija; Anant Patil
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.